Vericel

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Vericel and other ETFs, options, and stocks.

About VCEL

Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of patients with diseases. Its product portfolio includes MACI and Epicel. 

CEO
Dominick C. Colangelo
CEODominick C. Colangelo
Employees
398
Employees398
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
1989
Founded1989
Employees
398
Employees398

VCEL Key Statistics

Market cap
1.73B
Market cap1.73B
Price-Earnings ratio
107.61
Price-Earnings ratio107.61
Dividend yield
Dividend yield
Average volume
938.78K
Average volume938.78K
High today
High today
Low today
Low today
Open price
$34.10
Open price$34.10
Volume
0.00
Volume0.00
52 Week high
$45.97
52 Week high$45.97
52 Week low
$28.95
52 Week low$28.95

Stock Snapshot

As of today, Vericel(VCEL) shares are valued at $34.08. The company's market cap stands at 1.73B, with a P/E ratio of 107.61.

Vericel(VCEL) stock opened on 2026-04-07 at $34.10. The price climbed to — and dipped to —.

The Vericel(VCEL)'s current trading volume is 0, compared to an average daily volume of 938.78K.

In the last year, Vericel(VCEL) shares hit a 52-week high of $45.97 and a 52-week low of $28.95.

In the last year, Vericel(VCEL) shares hit a 52-week high of $45.97 and a 52-week low of $28.95.

VCEL News

Simply Wall St 16h
Why Vericel Is Up 11.8% After Landing Long-Term BARDA Deal For NexoBrid

MediWound Ltd. recently announced that Vericel Corporation, its exclusive North American distributor for NexoBrid, secured a ten-year BARDA contract worth up to...

Why Vericel Is Up 11.8% After Landing Long-Term BARDA Deal For NexoBrid
TipRanks 1d
Hold Rating on Vericel: BARDA Contract Validates NexoBrid but Premium Valuation Limits Upside

BTIG analyst Ryan Zimmerman has maintained their neutral stance on VCEL stock, giving a Hold rating on April 2. Unlock hedge fund-level data and powerful inves...

Simply Wall St 4d
Assessing Vericel Valuation After Winning A US$196.87 Million Government Contract

Advertisement Contract win reframes Vericel’s setup for investors Vericel (VCEL) recently secured a US$196.87 million contract with the Health and Human Servi...

Assessing Vericel Valuation After Winning A US$196.87 Million Government Contract

Analyst ratings

88%

of 8 ratings
Buy
87.5%
Hold
12.5%
Sell
0%

More VCEL News

TipRanks 5d
MediWound Highlights Vericel’s $197 Million BARDA Contract for NexoBrid

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

TipRanks 5d
MediWound says Vericel awarded ten-year contract valued at up to $197M

MediWound (MDWD) announced that Vericel (VCEL), its exclusive distributor of NexoBrid in North America, has been awarded a ten-year contract valued at up to $19...

TipRanks 5d
Vericel awarded Health and Human Services contract valued at $196.87M

Vericel (VCEL) has been awarded a contract by Health and Human Services with a total contract value of $196.87M. This acquisition will allow BARDA to support pr...

People also own

Based on the portfolios of people who own VCEL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.